The Lack of Effect of Botulinum Toxin-A on Upper Limb Activity in Chronic Stroke: A Short Report from the InTENSE Trial
Authors:
- Ian D. CameronICIan D. Cameron
- Louise AdaLALouise Ada
- Maria CrottyMCMaria Crotty
- Mithu PalitMPMithu Palit
- Lydia HuangLHLydia Huang
- John OlverJOJohn Olver
- Steven G. FauxSFSteven G. Faux
- Senen GonzalesSGSenen Gonzales
- Brian AnthoniszBABrian Anthonisz
- Malcolm BowmanMBMalcolm Bowman
- Yuriko WatanabeYWYuriko Watanabe
- Yan ChowYCYan Chow
Open Access
Abstract
We examined the effect of botulinum toxin-A on upper limb impairments and activity limitations in chronic stroke. This study is a secondary analysis of control group data from a national, multicenter, Phase III randomized trial with a masked outcome assessment. We studied 71 stroke survivors who received a botulinum toxin-A injection in any muscle(s) that crosses the wrist due to significant spasticity after a stroke greater than 3 months previously. We measured upper limb activity, spasticity, range of motion, grip strength, pain and other outcomes at injection and three months later. The median difference between injection and 3 months later was 0.0 blocks/s (interquartile range (IQR) 0.0) on the Box and Block Test, 0/4 (IQR 1) on the Tardieu Scale, 4 degrees (IQR 26) of wrist extension, 0.0 kg (IQR 2) of grip strength, 0.0 (IQR 1.5) on the 10 cm visual analogue scale for pain, 0/100 (IQR 21) on the 10 cm visual analogue scale for overall health, 0/3 (IQR 0) for self-care and −2 (IQR 8) for burden of care. In chronic stroke survivors who have little activity in their upper limb, botulinum toxin-A is not effective in improving any measured outcomes and does not appear to be clinically justified in this population with severe activity limitations.Keywords
Funding Information
- Australian National Health and Medical Research Council (GNT1079542, GNT102055)
- National Heart Foundation of Australia (GNT1079542, GNT102055)
This publication has 8 references indexed in Scilit:
- Longitudinal goal attainment with integrated upper limb spasticity management including repeat injections of botulinum toxin A: Findings from the prospective, observational Upper Limb International Spasticity (ULIS-III) cohort studyJournal of Rehabilitation Medicine, 2021
- Effect of Additional Rehabilitation After Botulinum Toxin-A on Upper Limb Activity in Chronic StrokeStroke, 2020
- Effect of adding upper limb rehabilitation to botulinum toxin-A on upper limb activity after stroke: Protocol for the InTENSE trialInternational Journal of Stroke, 2018
- Botulinum toxin as early intervention for spasticity after stroke or non-progressive brain lesion: A meta-analysisJournal of the Neurological Sciences, 2016
- Treatment With Botulinum Toxin Improves Upper-Extremity Function Post Stroke: A Systematic Review and Meta-AnalysisArchives of Physical Medicine and Rehabilitation, 2013
- A systematic review of the Tardieu Scale for the measurement of spasticityDisability and Rehabilitation, 2006
- Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trialJournal of Neurology, Neurosurgery & Psychiatry, 2000
- Adult Norms for the Box and Block Test of Manual DexterityAmerican Journal of Occupational Therapy, 1985